We retrieved the data for manageably small subsets of breast cancer from cBioportal [https://www.cbioportal.org/], identified their mutant TP53 molecules, and evaluated their phylogenetic analysis with the matrix methods versus three conventional algorithms for their relationships to quantitative clinical readouts. Here, TP53 is linked to breast cancer.